Bloqueio esfenopalatino no manejo do sono e sintomas depressivos em pacientes com fibromialgia: ensaio clínico randomizado.

Abstract

Fibromyalgia is a condition marked by the association of diffuse chronic pain with varied symptoms that include: fatigue, sleep disorders, cognitive dysfunction and episodes of depression, whose prevalencie is greater in the female sex. The treatment is m ult i d i s c i p l i n a r , involving pharmaceuticals, physical activity and cognitive terapias. The sphenopalatine ganglion block, a Proposed treatment for cranial and cranial pain syndromes facials, was used in case repor ts which evinced best time for different pain squares and symptoms neurocognitives. Our study is derived from a larger study which proposed to evaluate the effectiveness of this therapy in patients with fibromyalgie , being here on the edge the best in terms of of there of the symptoms of depresives, through a clinical trial double-blind, controlled place. They were 23 patients were randomized (14 in the ca í na group and 9 in the placebo ) and the companionship of the Pittsbutgh scale, Beck Depressation Inventary Like and rt. The results obtained do not show differences significatives between the two groups at no time study in relation to two variables (sound and symptoms depresives ). We conclude that there is no evidence in our study which indicates the use of the sphenopalatine ganglion block in patients with fibromyalgia pain, staining and other clinical trials performed in the 90s.